Y. Guan

Personal Home Page

http://www1.bjmu.edu.cn/E_bjmu/html/RESEARCH/phd super/jichu/new_page_13.htm

Articles in Scholarly Journals [Incomplete List]

  1. PPARs and Female Reproduction: Evidence from Genetically Manipulated Mice
    PPAR Research, vol. 2008, Article ID 723243, 8 pages, 2008
  2. Peroxisome Proliferator Activated Receptor  /  Dual Agonist Tesaglitazar Attenuates Diabetic Nephropathy in db/db Mice
    Diabetes, vol. 56, no. 8, pp. 2036–2045, 2007
  3. Liver-X-receptor activator prevents homocysteine-induced production of IgG antibodies from murine B lymphocytes via the ROS–NF-?B pathway
    Biochemical and Biophysical Research Communications, vol. 357, no. 3, pp. 772–778, 2007
  4. Laminar shear stress up-regulates the expression of stearoyl-CoA desaturase-1 in vascular endothelial cells
    Cardiovascular Research, vol. 74, no. 3, pp. 506–514, 2007
  5. Expression of mouse membrane-associated prostaglandin E2 synthase-2 (mPGES-2) along the urogenital tract
    Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol. 1761, no. 12, pp. 1459–1468, 2006
  6. Nuclear receptors link gender dimorphism of renal disease progression
    Kidney International, vol. 70, no. 11, Article ID 5001961, 1 pages, 2006
  7. Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel
    Journal of Clinical Investigation, vol. 116, no. 6, pp. 1696–1702, 2006
  8. Urine concentrating defect in prostaglandin EP1-deficient mice
    AJP: Renal Physiology, vol. 292, no. 2, pp. F868–F875, 2006
  9. Accelerated Diabetic Nephropathy in Mice Lacking the Peroxisome Proliferator-Activated Receptor  
    Diabetes, vol. 55, no. 4, pp. 885–893, 2006
  10. Increased severity of renal impairment in nephritic mice lacking the EP1 receptor
    Canadian Journal of Physiology and Pharmacology, vol. 84, no. 8-9, pp. 877–885, 2006
  11. Signal pathways underlying homocysteine-induced production of MCP-1 and IL-8 in cultured human whole blood
    Acta Pharmacologica Sinica, vol. 26, no. 1, pp. 85–91, 2005
  12. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines1
    Acta Pharmacologica Sinica, vol. 26, no. 6, pp. 753–761, 2005
  13. Liver X receptor agonist TO-901317 upregulates SCD1 expression in renal proximal straight tubule
    AJP: Renal Physiology, vol. 290, no. 5, pp. F1065–F1073, 2005
  14. Thiazolidinediones expand body fluid volume through PPAR? stimulation of ENaC-mediated renal salt absorption
    Nature Medicine, vol. 11, no. 8, Article ID nm1278, 5 pages, 2005
  15. Characterization of a Rabbit Kidney Prostaglandin F2  Receptor Exhibiting Gi-restricted Signaling That Inhibits Water Absorption in the Collecting Duct
    Journal of Biological Chemistry, vol. 280, no. 41, pp. 35028–35037, 2005
  16. C-Reactive Protein Augments Interleukin-8 Secretion in Human Peripheral Blood Monocytes
    Journal of Cardiovascular Pharmacology, vol. 46, no. 5, pp. 690–696, 2005
  17. Peroxisome proliferator?activated receptor- agonist rosiglitazone reduces clinical inflammatory responses in type 2 diabetes with coronary artery disease after coronary angioplasty
    Metabolism, vol. 54, no. 5, pp. 590–597, 2005
  18. Effect of deletion of the prostaglandin EP4 receptor on stimulation of calcium release from cultured mouse calvariae: Impaired responsiveness in heterozygotes
    Prostaglandins & Other Lipid Mediators, vol. 78, no. 1-4, pp. 19–26, 2005
  19. PPAR-? agonists and diabetic nephropathy
    Current Diabetes Reports, vol. 5, no. 6, pp. 470–475, 2005
  20. Generation of a conditional allele of the mouse prostaglandin EP4 receptor
    genesis, vol. 40, no. 1, pp. 7–14, 2004
  21. Membrane-associated PGE synthase-1 (mPGES-1) is coexpressed with both COX-1 and COX-2 in the kidney
    Kidney International, vol. 65, no. 4, pp. 1205–1213, 2004
  22. Anti-inflammatory Effect of PPAR? in Cultured Human Mesangial Cells
    Renal Failure, vol. 26, no. 5, pp. 497–505, 2004
  23. Peroxisome Proliferator-Activated Receptor Family and Its Relationship to Renal Complications of the Metabolic Syndrome
    Journal of the American Society of Nephrology, vol. 15, no. 11, pp. 2801–2815, 2004
  24. Liver X receptor-  mediates cholesterol efflux in glomerular mesangial cells
    AJP: Renal Physiology, vol. 287, no. 5, pp. F886–F895, 2004
  25. Prevention of Obesity and Insulin Resistance in Mice Lacking Plasminogen Activator Inhibitor 1
    Diabetes, vol. 53, no. 2, pp. 336–346, 2004
  26. Intense vortex pinning enhanced by semicrystalline defect traps in self-aligned nanostructured MgB2
    Applied Physics Letters, vol. 83, no. 2, p. 314, 2003
  27. Luminal NaCl delivery regulates basolateral PGE2 release from macula densa cells
    Journal of Clinical Investigation, vol. 112, no. 1, pp. 76–82, 2003
  28. Genomic structure and genitourinary expression of mouse cytosolic prostaglandin E2 synthase gene
    Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol. 1634, no. 1-2, pp. 15–23, 2003
  29. Generation and functional confirmation of a conditional null PPAR? allele in mice
    genesis, vol. 32, no. 2, pp. 134–137, 2002
  30. Peroxisome proliferator-activated receptors (PPARs): Novel therapeutic targets in renal disease
    Kidney International, vol. 61, no. 1, pp. 354–355, 2002
  31. Effects of different PPARgamma-agonists on MCP-1 expression and monocyte recruitment in experimental glomerulonephritis
    Kidney International, vol. 62, no. 2, pp. 455–464, 2002
  32. BMC Pharmacology, vol. 2, no. 1, p. 14, 2002
  33. The role of PPARs in the transcriptional control of cellular processes
    Drug News & Perspectives, vol. 15, no. 3, p. 147, 2002
  34. Nature Medicine, vol. 5, no. 2, pp. 217–220, 1999